Birgit M Reipert
5PUBLICATIONS
29CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jul 18, 2025
The interleukin-33 receptor (ST2) is a novel therapeutic target to attenuate the progression of hemophilic arthropathy.Heike C Hawerkamp, Aoife Yeow, Ciara M Byrne
|Apr 02, 2024
Immunogenicity profile of rurioctocog alfa pegol in previously treated patients with severe congenital hemophilia A.Frank M Horling, Birgit M Reipert, Peter Allacher
|Sep 08, 2022
Prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures during FVIII inhibitor eradication.Helmut Paul, Verena Berg, Bagirath Gangadharan
|Aug 10, 2022
Targets of autoantibodies in acquired hemophilia A are not restricted to factor VIII: data from the GTH-AH 01/2010 study.Olga Oleshko, Sonja Werwitzke, Annika Klingberg
|Nov 30, 2021
Nonneutralizing FVIII-specific antibody signatures in patients with hemophilia A and in healthy donors.Helmut Schweiger, Judit Rejtő, Christoph J Hofbauer
Pageof 1
Frequent Collaborators
2 joint publications
Helmut Schweiger
2 joint publications
Verena Berg
1 joint publications
Clemens Feistritzer
1 joint publications
Cihan Ay
1 joint publications
Olga Oleshko
1 joint publications
Robert Klamroth
1 joint publications
Christian Pfrepper
1 joint publications
Paul Knöbl
1 joint publications
Andreas Tiede
1 joint publications
Jan Blatný
